Recent advance in oxazole-based medicinal chemistry

被引:304
作者
Zhang, Hui-Zhen [1 ]
Zhao, Zhi-Long [1 ]
Zhou, Cheng-He [2 ]
机构
[1] Linyi Univ, Sch Pharm, Linyi 276000, Peoples R China
[2] Southwest Univ, Sch Chem & Chem Engn, Chongqing 400715, Peoples R China
基金
中国国家自然科学基金;
关键词
Oxazole; Biological activity; Medicinal chemistry; BETA-GLUCURONIDASE INHIBITORS; ACTIVITY-RELATIONSHIP SAR; IN-VIVO EVALUATION; CALF THYMUS DNA; BIOLOGICAL EVALUATION; MOLECULAR DOCKING; PHARMACOLOGICAL EVALUATION; HIGHLY POTENT; 1,3,4-OXADIAZOLE DERIVATIVES; BENZIMIDAZOLE DERIVATIVES;
D O I
10.1016/j.ejmech.2017.12.044
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Oxazole compounds containing nitrogen and oxygen atoms in the five-membered aromatic ring are readily able to bind with a variety of enzymes and receptors in biological systems via diverse non covalent interactions, and thus display versatile biological activities. The related researches in oxazole-based derivatives including oxazoles, isoxazoles, oxazolines, oxadiazoles, oxazolidones, benzoxazoles and so on, as medicinal drugs have been an extremely active topic, and numerous excellent achievements have been acquired. Noticeably, a large number of oxazole compounds as clinical drugs or candidates have been frequently employed for the treatment of various types of diseases, which have shown their large development value and wide potential as medicinal agents. This work systematically reviewed the recent researches and developments of the whole range of oxazole compounds as medicinal drugs, including antibacterial, antifungal, antiviral, antitubercular, anticancer, anti-inflammatory and analgesic, antidiabetic, antiparasitic, anti-obesitic, anti-neuropathic, antioxidative as well as other biological activities. The perspectives of the foreseeable future in the research and development of oxazole-based compounds as medicinal drugs are also presented. It is hoped that this review will serve as a stimulant for new thoughts in the quest for rational designs of more active and less toxic oxazole medicinal drugs. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:444 / 492
页数:49
相关论文
共 331 条
[1]   New 1,3,4-oxadiazole/oxime hybrids: Design, synthesis, anti-inflammatory, COX inhibitory activities and ulcerogenic liability [J].
Abd-Ellah, Heba S. ;
Abdel-Aziz, Mohamed ;
Shoman, Mai E. ;
Beshr, Eman A. M. ;
Kaoud, TamerS. ;
Ahmed, Al-Shaimaa F. F. .
BIOORGANIC CHEMISTRY, 2017, 74 :15-29
[2]   Novel 1,3,4-oxadiazole/oxime hybrids: Synthesis, docking studies and investigation of anti-inflammatory, ulcerogenic liability and analgesic activities [J].
Abd-Ellah, Heba S. ;
Abdel-Aziz, Mohamed ;
Shoman, Mai E. ;
Beshr, Eman A. M. ;
Kaoud, Tamer S. ;
Ahmed, Al-Shaimaa F. F. .
BIOORGANIC CHEMISTRY, 2016, 69 :48-63
[3]   Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents [J].
Abdelgawad, Mohamed A. ;
Bakr, Rania B. ;
Omar, Hany A. .
BIOORGANIC CHEMISTRY, 2017, 74 :82-90
[4]   Synthesis and antimycobacterial screening of new thiazolyl-oxazole derivatives [J].
Abhale, Yogita K. ;
Sasane, Amit V. ;
Chavan, Abhijit P. ;
Shekh, Saddam Husen ;
Deshmukh, Keshav K. ;
Bhansali, Sujit ;
Nawale, Laxman ;
Sarkar, Dhiman ;
Mhaske, Pravin C. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 132 :333-340
[5]   Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities [J].
Akhtar, Jawaid ;
Khan, Ahsan Ahmed ;
Ali, Zulphikar ;
Haider, Rafi ;
Yar, M. Shahar .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 125 :143-189
[6]   Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors [J].
Akhtar, Md Jawaid ;
Siddiqui, Anees Ahmad ;
Khan, Ahsan Ahmed ;
Ali, Zulphikar ;
Dewangan, Rikeshwer Prasad ;
Pasha, Santosh ;
Yar, M. Shahar .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 126 :853-869
[7]   Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety [J].
Al-Dosari, Mohammed S. ;
Ghorab, Mostafa M. ;
Al Said, Mansour S. ;
Nissan, Yassin M. ;
Ahmed, Abdulkareem B. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 69 :373-383
[8]   Synthesis of oxadiazole-morpholine derivatives and manifestation of the repressed CD31 Microvessel Density (MVD) as tumoral angiogenic parameters in Dalton's Lymphoma [J].
Al-Ghorbani, Mohammed ;
Vigneshwaran, V. ;
Ranganatha, V. Lakshmi ;
Prabhakar, B. T. ;
Khanum, Shaukath Ara .
BIOORGANIC CHEMISTRY, 2015, 60 :136-146
[9]   Discovery of structurally novel, potent and orally efficacious GPR119 agonists [J].
Alper, Phil ;
Azimioara, Mihai ;
Cow, Christopher ;
Mutnick, Daniel ;
Nikulin, Victor ;
Michellys, Pierre-Yves ;
Wang, Zhiliang ;
Reding, Esther ;
Paliotti, Michael ;
Li, Jing ;
Bao, Dingjiu ;
Zoll, Jocelyn ;
Kim, Young ;
Zimmerman, Matthew ;
Groessel, Todd ;
Tuntland, Tove ;
Joseph, Sean B. ;
McNamara, Peter ;
Seidel, H. Martin ;
Epple, Robert .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (10) :2383-2387
[10]   Synthesis of isoxazole-containing sulfonamides with potent carbonic anhydrase II and VII inhibitory properties [J].
Altug, Cevher ;
Gunes, Hanife ;
Nocentini, Alessio ;
Monti, Simona Maria ;
Buonanno, Martina ;
Supuran, Claudiu T. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (04) :1456-1464